MiR-422a weakened breast cancer stem cells properties by targeting PLP2.
Zou Y, Chen Y, Yao S, Deng G, Liu D, Yuan X, Liu S, Rao J, Xiong H, Yuan X, Yu S, Zhu F, Wang Y, Xiong H.
Zou Y, et al. Among authors: deng g.
Cancer Biol Ther. 2018 May 4;19(5):436-444. doi: 10.1080/15384047.2018.1433497. Epub 2018 Mar 30.
Cancer Biol Ther. 2018.
PMID: 29509055
Free PMC article.